Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: A systemic review and meta-analysis

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 3, 2013, Pages 450-463

  Sun, Yu ^a   Wei, Wei ^a   Yang, Hua Wei ^a   Liu, Jian Lun ^a  

^a Guangxi Cancer Institute   (China)

Author keywords

Breast neoplasm; Breast specific gamma imaging; Mammography; Meta analysis

Indexed keywords

BREAST CANCER; BREAST SPECIFIC GAMMA IMAGING; CANCER DIAGNOSIS; DIAGNOSTIC IMAGING; EMBASE; HUMAN; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MEDLINE; META ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; VALIDITY;

ANIMALS; BREAST; BREAST NEOPLASMS; HUMANS; MAMMOGRAPHY; ORGAN SPECIFICITY; RADIONUCLIDE IMAGING;

EID: 84874000894     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-012-2279-5     Document Type: Review

References (64)

1. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-92. doi: 10.1056/NEJMoa050518.
2. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico. Radiology. 1998;209(2):511-8.
3. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227-36. doi: 10.1056/NEJMoa062790.
4. Barlow WE, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff L, Carney PA, et al. Prospective breast cancer risk prediction model for women undergoing screening mammography. J Natl Cancer I. 2006;98(17):1204-14. doi: 10.1093/jnci/djj331.
5. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)- technetium-99 m by human carcinoma cell lines in vitro. Cancer Res. 1990;50(7):2198-202.
6. Sharma S, Sharma MC, Sarkar C. Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology. 2005;46(5):481-9. doi: 10.1111/j.1365-2559. 2005.02142.x.
7. Brem RF, Schoonjans JM, Kieper DA, Majewski S, Goodman S, Civelek C. High-resolution scintimammography: a pilot study. J Nucl Med. 2002;43(7):909-15.
8. Spanu A, Cottu P, Manca A, Chessa F, Sanna D, Madeddu G. Scintimammography with dedicated breast camera in unifocal and multifocal/multicentric primary breast cancer detection: a comparative study with SPECT. Int J Oncol. 2007;31(2):369-77.
9. Hruskaa CB, O'Connor MK. Quantification of lesion size, depth, and uptake using a dual-head molecular breast imaging system. Med Phys. 2008;35(4):1365-76.
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol. 2003;3:25. doi: 10.1186/1471-2288-3-25.
11. Irwig L, Tosteson AN, Gatsonis C, Lau J, Colditz G, Chalmers TC, et al. Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med. 1994;120(8):667-76.
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60. doi: 10.1136/bmj.327.7414.557.
13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-88.
14. Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta-analysis of clinical trials with binary outcomes. Stat Med. 2000;19(24):3417-32.
15. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29(7):1043-51. doi: 10.1007/s00134-003-1761-8.
16. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994;271(9):703-7.
17. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PM. The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol. 2003;56(11):1129-35.
18. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982-90. doi: 10.1016/j.jclinepi.2005.02.022.
19. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med. 1993;12(14):1293-316.
20. Deeks JJ, Macaskill P, Irwig L. The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol. 2005;58(9):882-93. doi: 10.1016/j.jclinepi.2005.01.016.
21. Coover LR, Caravaglia G, Kuhn P. Scintimammography with dedicated breast camera detects and localizes occult carcinoma. J Nucl Med. 2004;45(4):553-8.
22. Brem RF, Rapelyea JA, Zisman G, Mohtashemi K, Raub J, Teal CB, et al. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer. Radiology. 2005;237(1):274-80. doi: 10.1148/radiol.2371040758.
23. Schillaci O, Cossu E, Romano P, Sanso C, Danieli R, Granai AV, et al. High-resolution gamma-camera for molecular breast imaging: first clinical results. Phys Med. 2006;21 Suppl 1:121-4. doi: 10.1016/S1120-1797(06)80042-6.
24. Brem RF, Fishman M, Rapelyea JA. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study. Acad Radiol. 2007;14(8):945-50. doi: 10.1016/j.acra.2007. 04.004.
25. O'Connor MK, Phillips SW, Hruska CB, Rhodes DJ, Collins DA. Molecular breast imaging: advantages and limitations of a scintimammographic technique in patients with small breast tumors. Breast J. 2007;13(1):3-11. doi: 10.1111/j.1524-4741.2006.00356.x.
26. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology. 2008;247(3):651-7. doi: 10.1148/radiol.2473061678.
27. Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 2008;191(6):1805-15. doi: 10.2214/AJR.07.3693.
28. Zhou M, Johnson N, Blanchard D, Bryn S, Nelson J. Real-world application of breast-specific gamma imaging, initial experience at a community breast center and its potential impact on clinical care. Am J Surg. 2008;195(5):631-5. doi: 10.1016/j.amjsurg.2008.01.006. discussion 5.
29. Zhou M, Johnson N, Gruner S, Ecklund GW, Meunier P, Bryn S, et al. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. Am J Surg. 2009;197(2):159-63. doi: 10.1016/j.amjsurg.2008.10.002.
30. Killelea BK, Gillego A, Kirstein LJ, Asad J, Shpilko M, Shah A, et al. George Peters Award: How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer? Am J Surg. 2009;198(4):470-4. doi: 10.1016/j.amjsurg.2009.06.016.
31. Brem RF, Shahan C, Rapleyea JA, Donnelly CA, Rechtman LR, Kidwell AB, et al. Detection of occult foci of breast cancer using breast-specific gamma imaging in women with one mammographic or clinically suspicious breast lesion. Acad Radiol. 2010;17(6):735-43. doi: 10.1016/j.acra.2010.01.017.
32. Kessler R, Sutcliffe JB, Bell L, Bradley YC, Anderson S, Banks KP. Negative predictive value of breast-specific gamma imaging in low suspicion breast lesions: a potential means for reducing benign biopsies. Breast J. 2011;17(3):319-21. doi: 10.1111/j.1524-4741.2011.01077.x.
33. Siegal E, Angelakis E, Morris P, Pinkus E. Breast molecular imaging: a retrospective review of one institutions experience with this modality and analysis of its potential role in breast imaging decision making. Breast J. 2012;18(2):111-7. doi: 10.1111/j.1524-4741.2011.01214.x.
34. Weigert JM, Bertrand ML, Lanzkowsky L, Stern LH, Kieper DA. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. AJR Am J Roentgenol. 2012;198(1):W69-75. doi: 10.2214/AJR.10.6105.
35. Keto JL, Kirstein L, Sanchez DP, Fulop T, McPartland L, Cohen I, et al. MRI versus breast-specific gamma imaging (BSGI) in newly diagnosed ductal cell carcinoma-in-situ: a prospective head-to-head trial. Ann Surg Oncol. 2012;19(1):249-52. doi: 10.1245/s10434-011-1848-3.
36. Spanu A, Sanna D, Chessa F, Manca A, Cottu P, Fancellu A, et al. The clinical impact of breast scintigraphy acquired with a breast specific gamma-camera (BSGC) in the diagnosis of breast cancer: incremental value versus mammography. Int J Oncol. 2012;41(2):483-9. doi: 10.3892/ijo.2012.1495.
37. Spanu A, Sanna D, Chessa F, Cottu P, Manca A, Madeddu G. Breast scintigraphy with breast-specific γ-camera in the detection of ductal carcinoma in situ: a correlation with mammography and histologic subtype. J Nucl Med. 2012;53(10):1528-33. doi: 10.2967/jnumed.112.103010.
38. Lee A, Chang J, Lim W, Kim BS, Lee JE, Cha ES et al. Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study. Breast J. 2012;18(5):453-8. doi: 10.1111/j.1524-4741.2012.01280.x.
39. Kim BS, Moon BI, Cha ES. A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts. Ann Nucl Med. 2012. doi: 10.1007/s12149-012-0649-5.
40. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63(1):181-7.
41. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer I. 2002;94(20):1546-54.
42. Ernster VL, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr. 1997;22:151-6.
43. Barreau B, de Mascarel I, Feuga C, MacGrogan G, Dilhuydy MH, Picot V, et al. Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations. Eur J Radiol. 2005;54(1):55-61. doi: 10.1016/j.ejrad.2004.11.019.
44. Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology. 1989;170(2):411-5.
45. Menell JH, Morris EA, Dershaw DD, Abramson AF, Brogi E, Liberman L. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J. 2005;11(6):382-90. doi: 10.1111/j.1075-122X.2005.00121.x.
46. Berg WA, Gutierrez L, NessAiver MS, Carter WB, Bhargavan M, Lewis RS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233(3):830-49. doi: 10.1148/radiol.2333031484.
47. Sickles EA. The subtle and atypical mammographic features of invasive lobular carcinoma. Radiology. 1991;178(1):25-6.
48. Krecke KN, Gisvold JJ. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161(5):957-60.
49. Uchiyama N, Miyakawa K, Moriyama N, Kumazaki T. Radiographic features of invasive lobular carcinoma of the breast. Radiat Med. 2001;19(1):19-25.
50. Brem RF, Ioffe M, Rapelyea JA, Yost KG, Weigert JM, Bertrand ML, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol. 2009;192(2):379-83. doi: 10.2214/AJR.07.3827.
51. Ling CM, Coffey CM, Rapelyea JA, Torrente J, Teal CB, McSwain AP, et al. Breast-specific gamma imaging in the detection of atypical ductal hyperplasia and lobular neoplasia. Acad Radiol. 2012;19(6):661-6. doi: 10.1016/j.acra.2012. 02.008.
52. Spanu A, Farris A, Chessa F, Sanna D, Pittalis M, Manca A, et al. Planar scintimammography and SPECT in neoadjuvant chemo or hormonotherapy response evaluation in locally advanced primary breast cancer. Int J Oncol. 2008;32(6):1275-83.
53. O'Connor MK, Li H, Rhodes DJ, Hruska CB, Clancy CB, Vetter RJ. Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. Med Phys. 2010;37(12):6187-98.
54. Rhodes DJ, O'Connor MK, Phillips SW, Smith RL, Collins DA. Molecular breast imaging: a new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. Mayo Clinic Proc. 2005;80(1):24-30. doi: 10.1016/S0025-6196(11)62953-4.
55. Dibble SL, Israel J, Nussey B, Sayre JW, Brenner RJ, Sickles EA. Mammography with breast cushions. Womens Health Issues. 2005;15(2):55-63. doi: 10.1016/j.whi.2004.12.001.
56. Kim BS. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI. Ann Nucl Med. 2012;26(2):131-7. doi: 10.1007/s12149-011-0544-5.
57. Goldsmith SJ, Parsons W, Guiberteau MJ, Stern LH, Lanzkowsky L, Weigert J, et al. SNM practice guideline for breast scintigraphy with breast-specific gamma-cameras 1.0. J Nucl Med Technol. 2010;38(4):219-24. doi: 10.2967/jnmt.110.082271.
58. Conners AL, Hruska CB, Tortorelli CL, Maxwell RW, Rhodes DJ, Boughey JC, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2012;39(6):971-82. doi: 10.1007/s00259-011-2054-z.
59. Spanu A, Chessa F, Sanna D, Cottu P, Manca A, Nuvoli S, et al. Breast cancer axillary lymph node metastasis detection by a high-resolution dedicated breast camera: a comparative study with SPECT and pinhole SPECT. Cancer Biother Radiopharm. 2007;22(6):799-811. doi: 10.1089/cbr.2007.367.
60. Jones EA, Phan TD, Johnson NM, Blanchard DA. A protocol for imaging axillary lymph nodes in patients undergoing breast-specific gamma-imaging. J Nucl Med Technol. 2010;38(1):28-31. doi: 10.2967/jnmt.109.062711.
61. Welch BL, Brem R, Black R, Majewski S. Quality assurance procedure for a gamma guided stereotactic breast biopsy system. Phys Med. 2006;21 Suppl 1:102-5. doi: 10.1016/S1120-1797(06)80037-2.
62. Rhodes DJ, Hruska CB, Phillips SW, Whaley DH, O'Connor MK. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology. 2011;258(1):106-18. doi: 10.1148/radiol.10100625.
63. Hruska CB, Weinmann AL, O'Connor MK. Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part I. Evaluation in phantoms. Med Phys. 2012;39(6):3466-75. doi: 10.1118/1.4718665.
64. Hruska CB, Weinmann AL, Tello Skjerseth CM, Wagenaar EM, Conners AL, Tortorelli CL, et al. Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients. Med Phys. 2012;39(6):3476-83. doi: 10.1118/1.4719959.